Cubist Systematic Strategies, LLC Moderna, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $3.33 Million - $5.48 Million	-32,900 Reduced 9.93%	298,300 $35.4 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $8.9 Million - $12 Million	-104,200 Reduced 23.93%	331,200 $35.3 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.86 Million - $4.3 Million	41,200 Added 10.45%	435,400 $43.3 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $8.08 Million - $10.6 Million	83,800 Added 27.0%	394,200 $40.7 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $9.98 Million - $13.5 Million	84,200 Added 37.22%	310,400 $37.7 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $11.8 Million - $17.1 Million	86,900 Added 62.38%	226,200 $34.7 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $9.47 Million - $16.8 Million	80,000 Added 134.91%	139,300 $25 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.74 Million - $2.85 Million	-14,700 Reduced 19.86%	59,300 $7.01 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $8.67 Million - $13.1 Million	74,000 New	74,000 $10.6 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.